Predictive value of early magnetic resonance imaging measures is differentially affected by the dose of interferon beta-1a given subcutaneously three times a week: an exploratory analysis of the PRISMS study

BACKGROUND: On-treatment magnetic resonance imaging lesions may predict long-term clinical outcomes in patients receiving interferon β-1a. This study aimed to assess the effect of active T2 and T1 gadolinium-enhancing (Gd+) lesions on relapses and 3-month confirmed Expanded Disability Status Scale (...

Descripción completa

Detalles Bibliográficos
Autores principales: Traboulsee, Anthony, Li, David K. B., Cascione, Mark, Fang, Juanzhi, Dangond, Fernando, Miller, Aaron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5946401/
https://www.ncbi.nlm.nih.gov/pubmed/29751787
http://dx.doi.org/10.1186/s12883-018-1066-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5946401/
https://www.ncbi.nlm.nih.gov/pubmed/29751787
http://dx.doi.org/10.1186/s12883-018-1066-8

Ejemplares similares